3 completed, 1 terminated. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Terminated 1 |
Follow sitaxsentan: new trials by email Literature Review of sitaxsentan trials Research Report on sitaxsentan
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study on the Effects of Sitaxsentan on Airway Remodeling in Patients With Severe Asthma sitaxentan, placebo - Effect of Sitaxsentan on Airway Remodeling in Severe Asthma | Phase 2 | Terminated | Institut National de la Santé Et de la Recherche Médicale, France | 17 | 2009-11-01 | 2012-05-10 |
| Sitaxsentan in Proteinuric Chronic Kidney Disease Sitaxsentan, Nifedipine, Placebo tablet - Chronic Kidney Disease, Proteinuria | Phase 2 | Completed | University of Edinburgh | 27 | 2007-07-14 | 2025-02-07 |
| Effects Of Sitaxsentan On Proteinuria, 24-Hour Blood Pressure, And Arterial Stiffness In Chronic Kidney Disease Subjects Open, Nifedipine, Placebo - Chronic Kidney Disease | Phase 2 | Completed | Pfizer | 27 | 2007-05-09 | 2023-07-06 |
| Confirming The Sitaxsentan Dose In Patients Undergoing Heart Surgery sitaxsentan (Thelin), Placebo - Cardiac Surgery Subjects, Subjects Undergoing CABG and/or Cardiac Valve Replacement | Phase 2 | Completed | Pfizer | 29 | 2006-08-10 | 2022-09-08 |
Renal Insufficiency, Chronic (2) · Airway Obstruction (1) · Airway Remodeling (1) · Asthma (1) · Proteinuria (1)
Pfizer (2) · Institut National de la Santé Et de la Recherche Médicale, France (1) · University of Edinburgh (1)
United Kingdom (2) · France (1) · United States (1)
David Webb, MD DSc FRCP FRSE FMedSci (1) · Neeraj Dhaun, MBChB (1)
PMID 21357275, PMID 23243212, PMID 24890823, PMID 25801761, PMID 31177906